Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-002516

Options or other derivatives

  • Chief Financial Officer acquired 180,922 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tsuchimoto Kim R · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-02-01 Grant or award : show line 1 in the form Stock Options +102,688 102,688 D
2023-02-01 Grant or award : show line 2 in the form Restricted Stock Units +78,234 135,382 D
Loading xslF345X03/rdgdoc.xml…